Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

615
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
615
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

241
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
241
Dementia01:30

Dementia

153
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
153
Neural Regulation01:37

Neural Regulation

39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep-learning analysis of speech using mel-spectrograms for the assessment of mild cognitive impairment and Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2025
Same author

Prediction of Diagnosis and Treatment Response in Adolescents With Depression by Using a Smartphone App and Deep Learning Approaches: Usability Study.

JMIR formative research·2023
Same author

Feature Selection Method Using Multi-Agent Reinforcement Learning Based on Guide Agents.

Sensors (Basel, Switzerland)·2023
Same author

A hierarchical two-phase framework for selecting genes in cancer datasets with a neuro-fuzzy system.

Technology and health care : official journal of the European Society for Engineering and Medicine·2016
Same author

Fuzzy Naive Bayesian for constructing regulated network with weights.

Bio-medical materials and engineering·2015
Same author

Interactive Naive Bayesian network: A new approach of constructing gene-gene interaction network for cancer classification.

Bio-medical materials and engineering·2015
Same journal

RETRACTED: Zhang et al. A Novel Framework for Reconstruction and Imaging of Target Scattering Centers via Wide-Angle Incidence in Radar Networks. <i>Sensors</i> 2025, <i>25</i>, 6802.

Sensors (Basel, Switzerland)·2026
Same journal

Enhancing Unsupervised Multi-Source Domain Adaptation for Person Re-Identification via Mixture of Experts and Graph-Based Relation.

Sensors (Basel, Switzerland)·2026
Same journal

Development of an Instrumented Glove for Palmar Pressure Assessment in Kayakers.

Sensors (Basel, Switzerland)·2026
Same journal

Development and Experimental Validation of an Autonomous IoT-Based Monitoring System for Real-Time Water Quality Assessment in the Amazon River.

Sensors (Basel, Switzerland)·2026
Same journal

Semi-Supervised Adversarial Learning Framework for Controller Area Network Bus Intrusion Detection.

Sensors (Basel, Switzerland)·2026
Same journal

Smart Optimization Method for Safety Signs in Innovative Manufacturing Environments Integrating Industrial Field IoT Sensors and Knowledge Graphs.

Sensors (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Aug 19, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Zoom-In Neural Network Deep-Learning Model for Alzheimer's Disease Assessments.

Bohyun Wang1, Joon S Lim1

  • 1Department of Computer Science, Gachon University, Sujeong-gu, Seongnam-si 13557, Gyeonggi-do, Republic of Korea.

Sensors (Basel, Switzerland)
|November 26, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a novel deep learning algorithm, the zoom-in neural network (ZNN), for Alzheimer's disease (AD) detection. ZNN accurately differentiates between AD, mild cognitive impairment (MCI), and normal control (NC) using brain imaging data.

Keywords:
AAL functional regionsAlzheimer’s diseasedeep neural networksdiscriminative regions of interest of Alzheimer’s diseasemetacognitive learningresting-state fMRI

More Related Videos

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

612
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
06:02

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

36.8K

Related Experiment Videos

Last Updated: Aug 19, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

612
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
06:02

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

36.8K

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Deep neural networks (DNNs) show promise in analyzing complex medical data.
  • Alzheimer's disease (AD) and mild cognitive impairment (MCI) require accurate diagnostic tools.

Purpose of the Study:

  • To evaluate the efficacy of a novel deep-learning algorithm, the zoom-in neural network (ZNN), for classifying individuals with AD, MCI, and normal controls (NC).
  • To identify brain regions implicated in AD progression using neuroimaging data.

Main Methods:

  • Utilized a deep-learning algorithm, the zoom-in neural network (ZNN), which employs a hierarchical structure of zoom-in learning units (ZLUs) without backpropagation.
  • Employed resting-state functional magnetic resonance imaging (rs-fMRI) data from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
  • Applied the Automated Anatomical Labeling (AAL-90) atlas to analyze 90 neuroanatomical regions and extracted features from 140-time series rs-fMRI voxel values.

Main Results:

  • Achieved high classification accuracies: 97.7% for AD vs. MCI and NC, 84.8% for NC vs. AD and MCI, and 72.7% for MCI vs. AD and NC.
  • Identified seven discriminative regions of interest (ROIs) within the AAL-90 atlas crucial for classification.

Conclusions:

  • The ZNN deep-learning algorithm demonstrates significant potential for accurate AD and MCI assessment using rs-fMRI data.
  • The identified ROIs offer insights into the neuroanatomical underpinnings of AD and MCI.